CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
מצבים רפואיים
Diffuse Midline Glioma, H3 K27-Altered · Metastatic Malignant Neoplasm in the Central Nervous System · Recurrent Diffuse Intrinsic Pontine Glioma · Recurrent Diffuse Midline Glioma, H3 K27-Altered · Recurrent Lymphoma · Recurrent Malignant Solid Neoplasm · Recurrent Primary Malignant Central Nervous System Neoplasm · Refractory Lymphoma · Refractory Malignant Solid Neoplasm · Refractory Primary Malignant Central Nervous System Neoplasm
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Children's Hospital of Alabama, Birmingham, Alabama, United States
Contact: Principal Investigator (Girish Dhall)Phoenix Childrens Hospital, Phoenix, Arizona, United States
Contact: Principal Investigator (Alok K. Kothari)Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Fariba Navid)Children's Hospital of Orange County, Orange, California, United States
Contact: Principal Investigator (Josephine H. Haduong)UCSF Medical Center-Mission Bay, San Francisco, California, United States
Contact: Principal Investigator (Kieuhoa T. Vo)Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Margaret E. Macy)Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Site Public Contact) · OncCRC_OnCall@childrensnational.org · 202-476-2800Contact: Principal Investigator (AeRang Kim)Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Contact: Principal Investigator (Jonathan L. Metts)Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jason R. Fangusaro)Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Elizabeth A. Sokol)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Ami V. Desai)Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Principal Investigator (Brian D. Weiss)Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Christine A. Pratilas)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Steven G. DuBois)C S Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rajen Mody)University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Robin L. Williams)Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
Contact: Principal Investigator (Kevin F. Ginn)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Shalini Shenoy)Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Clare J. Twist)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Nobuko Hijiya)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Julia L. Glade Bender)New York Medical College, Valhalla, New York, United States
Contact: Principal Investigator (Mitchell S. Cairo)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Jessica M. Sun)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Joseph G. Pressey)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Bill H. Chang)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Theodore W. Laetsch)Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Andrew Bukowinski)Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Dana Tlais)UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097Contact: Principal Investigator (Laura J. Klesse)Cook Children's Medical Center, Fort Worth, Texas, United States
Contact: Study coordinator (Site Public Contact) · CookChildrensResearch@cookchildrens.org · 682-885-2103Contact: Principal Investigator (Sibo Zhao)Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jennifer H. Foster)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Matthew Dietz)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Principal Investigator (Katherine G. Tarlock)Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Sarah Rumler)Sydney Children's Hospital, Randwick, New South Wales, Australia
מובילי המחקר
David S Ziegler
Principal Investigator
Pediatric Early Phase Clinical Trial Network